Predictive Genetic Testing And Consumer/Wellness Genomics Market

Predictive genetic testing is relatively new but rapidly emerging arena in public health practices, especially in developed nations. It is increasingly being used to guide nutritional strategies and training outcomes for a number of disorders. While wellness genomics is used to assist persons to take appropriate health decisions that promotes their wellness and help in maintenance of better health. It typically includes various genotypic and clinical information.

Predictive Genetic Testing And Consumer/Wellness Genomics Market contains market size and forecasts of Predictive Genetic Testing And Consumer/Wellness Genomics in Global, including the following market information:

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Predictive Genetic Testing And Consumer/Wellness Genomics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Predictive Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Predictive Genetic Testing And Consumer/Wellness Genomics include Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics and ARUP Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Predictive Genetic Testing And Consumer/Wellness Genomics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Segment Percentages, by Type, 2021 (%)

Predictive Testing

Consumer Genomics

Wellness Genomics

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Segment Percentages, by Application, 2021 (%)

Breast & Ovarian Cancer

Cardiovascular Screening

Diabetic Screening & Monitoring

Colon Cancer

Other

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Predictive Genetic Testing And Consumer/Wellness Genomics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Predictive Genetic Testing And Consumer/Wellness Genomics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Illumina

BGI

Genesis Genetics

Myriad Genetics

23andMe, Inc

Color Genomics Inc

Pathway Genomics

ARUP Laboratories